Please assess the completion status of the following clinical trial:

Trial Title: A Study to Evaluate the Safety of Two Influenza Vaccines in Children and Adolescents 3 to <18 Years of Age at Risk for Influenza-Related Complications

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Individuals 3 to \<18 years of age with underlying medical conditions that indicate an increased risk of complications from influenza infection.~* Further eligibility criteria may be discussed by contacting the site(s)~Exclusion Criteria:~* Individuals with any fatal prognosis of an underlying medical condition (\<12 month life expectancy).~* Individuals hospitalized at the time of enrolment.~* Individuals with a history of any anaphylaxis, serious vaccine reactions, or hypersensitivity to any of the vaccine components.~* Further eligibility criteria may be discussed by contacting the site(s)

- Gender: ALL
- Minimum Age: 3 Years
- Maximum Age: 17 Years
- Healthy Volunteers: t

Study Arms:
- TIVc (Type: EXPERIMENTAL): flu vaccine
- TIV (Type: ACTIVE_COMPARATOR): flu vaccine

Based on this trial design, predict the completion outcome and termination type (if applicable).